Safety and Efficacy of Therapeutic INduced HYPERTENSION in Acute Non-cardioembolic Ischemic Stroke (SETIN-HYPERTENSION)
Safety and Efficacy of Therapeutic Induced Hypertension in Patients With Acute Non-cardioembolic Ischemic Stroke: A Multicenter, Randomized, Open Label, Prospective, Phase 3 Study
Sponsor: Gyeongsang National University Hospital
Listed as NCT01600235, this PHASE3 trial focuses on Progressing Stroke and Stroke, Acute and remains ongoing. Sponsored by Gyeongsang National University Hospital, it has been updated 9 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE3
-
May 2019 — Jan 2021 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
▶ Show 4 earlier versions
-
Jun 2018 — May 2019 [monthly]
Recruiting PHASE3
-
Jun 2017 — Jun 2018 [monthly]
Recruiting PHASE3
-
May 2017 — Jun 2017 [monthly]
Recruiting PHASE3
Status: Unknown Status → Recruiting
-
Jan 2017 — May 2017 [monthly]
Unknown Status PHASE3
First recorded
Jun 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Gyeongsang National University Hospital
- Inje University
- Keimyung University Dongsan Medical Center
- Samsung Medical Center
- Seoul National University Bundang Hospital
- Yeungnam University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .